Saturday, July 11, 2026

Drug profile · INN

efavaleukin

efavaleukin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — efavaleukin
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

efavaleukin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN efavaleukin

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 20170104 Phase 2 · Amgen · Ulcerative Colitis (UC)
  2. 20210210 Phase 2 · Amgen · Ulcerative Colitis (UC)
  3. Efavaleukin alfa Phase 2 · Amgen · Ulcerative Colitis

Frequently asked questions

What is efavaleukin?

efavaleukin is an FDA-listed pharmaceutical active ingredient.